Renal fibrosis is the final manifestation of various chronic kidney diseases. Interstitial myofibroblasts, which are reported to highly express integrin αvβ3, are the effector cells in renal ...

Conclusions These results uncover dynamic transition of peripheral blood immune cells during flare of lupus nephritis, especially in CD8+ T cell population, suggesting its pivotal roles in SLE ...

Dr. Kimberly Trotter distilled four high-impact disease clusters—gout, rheumatoid arthritis (RA), systemic lupus ...

Young adults in Vietnam are suffering from kidney failure after consuming unregulated weight loss pills and supplements but ...

Background Proliferative lupus nephritis (LN) is characterized by robust glomerular and tubulo- interstitial inflammation, sub-endothelial deposits of immunoglobulin, and increased endothelial cell ...

MONDAY, June 30, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved an autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with ...

FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis Jun 30, 2025 Updated Jun 30, 2025 0 ...

Benlysta (200 mg/mL), a B-lymphocyte stimulator-specific inhibiting monoclonal antibody, is the first and only approved biologic for both systemic lupus erythematosus and lupus nephritis. It is ...

FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis Jun 30, 2025 Updated Jun 30, 2025 autoinjector needle injection pen ...

FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis Jun 30, 2025 1 min to read autoinjector needle injection pen ...